Altium Capital Management LLC / SGMT
Altium Capital Management LLC’s Sagimet Biosciences Inc Position
Does Altium Capital Management LLC own Sagimet Biosciences Inc (SGMT)? Not currently — the last reported position was 483.2K shares worth $3M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q4 2023
Shares
483.2K
% of Portfolio
+1.72%
Quarters Held
2
position exited
Position History SGMT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of SGMT.